Richard J Vickers Selected Research

Dysbiosis

1/2020

Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard J Vickers Research Topics

Disease

4	Clostridium Infections 01/2020 - 01/2015
4	Infections 01/2018 - 01/2015
1	Dysbiosis 01/2020

Drug/Important Bio-Agent (IBA)

4	ridinilazoleIBA 01/2020 - 01/2015
3	Vancomycin FDA LinkGeneric 01/2018 - 01/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2016
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	FidaxomicinIBA 01/2015

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2015